Effect of SHR8058 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction

Acupuncture Treatment of Dry Eye

NCT00554879 ·Status: COMPLETED ·Phase: NA

Pharmacokinetics, Safety, and Tolerability of rhEGF Eye Drops in Healthy Male Subjects

NCT05219461 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease

NCT06717152 ·Status: COMPLETED ·Phase: PHASE3

[KSR-001-P02] Phase 2b/3 Study, Evaluate the Efficacy and Safety of KSR-001 in Patients With Dry Eye Syndrome

NCT05017844 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

The Effects of a Single Intravenous Administration of Secukinumab (AIN457) or Canakinumab (ACZ885) in Dry Eye Patients

NCT01250171 ·Status: COMPLETED ·Phase: PHASE2

A Randomized, Parallel-Group Comparison Study of Topical Corticosteroids in Dry Eye Patients With Sjögren Syndrome

NCT02011776 ·Status: COMPLETED

Study of DE-089 Ophthalmic Solution in Patients With Dry Eye

NCT01101984 ·Status: COMPLETED ·Phase: NA

Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient with Moderate to Severe Dry Eye

NCT06860659 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4

To Evaluate the Efficacy and Safety of HUC3-053 in Patients With Dry Eye Syndrome

NCT06388070 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye Disease

NCT01562795 ·Status: COMPLETED ·Phase: NA

Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease

NCT04541888 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease

NCT05865379 ·Status: RECRUITING ·Phase: NA

To Evaluate the Short-term and Long Term Efficacy of Acupuncture in Ocular and Oral Dryness Symptoms of Dry Eye Syndrome

NCT04877483 ·Status: UNKNOWN ·Phase: NA

The Germinal Peptide Eye Drops in Healthy Volunteers in a Clinical Study

NCT03967548 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye

NCT05848128 ·Status: COMPLETED ·Phase: PHASE3

A Study of AG-80308 in Dry Eye Patients

NCT05372107 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of BUFY02 Versus TRB02 in the Treatment of Dry Eye Disease

NCT05865457 ·Status: RECRUITING ·Phase: NA

Effect of Preservative-free Low-dose Hyaluronic Acid-containing Salt Solution on Dry Eye Disease

NCT03888183 ·Status: UNKNOWN ·Phase: PHASE4

A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease

NCT05238597 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Safety and Efficacy of rhNGF Eye Solution vs Vehicle in Patients With Moderate to Severe Dry Eye

NCT03982368 ·Status: COMPLETED ·Phase: PHASE2

Study of SY-201 Ophthalmic Solution in Subjects With Dry Eye Disease

NCT05370495 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Perfluorohexyloctane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)

NCT03333057 ·Status: COMPLETED ·Phase: PHASE2

Managing Dry Eye in Patients Using Glaucoma Drops

NCT06158984 ·Status: COMPLETED ·Phase: NA

An 8-week Study to Evaluate Safety and Efficacy of NGF Eye Drops Solution Versus Vehicle in Patients With Dry Eye

NCT03019627 ·Status: COMPLETED ·Phase: PHASE2

Examining the Clinical Characteristics, Treatment Patterns, Real-world Effectiveness, and Healthcare Resource Utilization of Patients With Dry Eye Disease

NCT05857748 ·Status: WITHDRAWN